Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of PRO-190 vs Systane Ultra in Healthy Volunteers
NCT06379685Phase 1Not yet recruiting
- Sponsor
- Laboratorios Sophia
- Start
- Dec 2025
- Primary completion
- Dec 2026
01
Overview
Phase 1, randomised trial of PRO-190 in dry eye syndrome (DED) (2 arms), sponsored by Laboratorios Sophia. Primary endpoint: Incidence Unexpected Related Adverse Reactions at Day 12. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
PRO-190
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT06379685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06379685.